<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Cozaar preparations; Losartan: hydrochlorothiazide with; Hydrochlorothiazide: losartan with" /><meta name="IX" content="Cozaar preparations; Losartan: hydrochlorothiazide with; Hydrochlorothiazide: losartan with" /><title>Cozaar-Comp®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="60326.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="60326.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=60326.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="1002.htm">2 Cardiovascular system</a> &gt; <a href="2534.htm">2.5 Hypertension and heart failure</a> &gt; <a href="27510.htm">2.5.5 Drugs affecting the renin-angiotensin system</a> &gt; <a href="27513.htm">2.5.5.2 Angiotensin-II receptor antagonists</a> &gt; <a href="27526.htm">LOSARTAN POTASSIUM</a> &gt; <a href="60325.htm">With diuretic</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="64883.htm" title="Previous: IRBESARTAN">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="127965.htm" title="Next: OLMESARTAN MEDOXOMIL">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a395008.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Losartan Potassium</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Cardiovascular Drugs 24:00 &gt; Renin-Angiotensin-Aldosterone System Inhibitors 24:32 &gt; Angiotensin II Receptor Antagonists 24:32.08</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/17223-s.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Losartan</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: L &gt; Interactions of Losartan</p></div></li></ul><ul><li><h3>British National Formulary (5)</h3></li><li><a href="27513.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.5.5.2 Angiotensin-II receptor antagonists</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension and heart failure &gt; 2.5.5 Drugs affecting the renin-angiotensin system</p></div></li><li><a href="27526.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">LOSARTAN POTASSIUM</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension and heart failure &gt; 2.5.5 Drugs affecting the renin-angiotensin system &gt; 2.5.5.2 Angiotensin-II receptor antagonists</p></div></li><li><a href="208577.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Losartan Potassium</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension and heart failure &gt; 2.5.5 Drugs affecting the renin-angiotensin system &gt; 2.5.5.2 Angiotensin-II receptor antagonists &gt; LOSARTAN POTASSIUM</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22losartan+potassium%22%22losartan%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>BNF for Children (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/27513.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.5.5.2 Angiotensin-II receptor antagonists</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension &gt; 2.5.5 Drugs affecting the renin-angiotensin system</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/27526.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">LOSARTAN POTASSIUM</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension &gt; 2.5.5 Drugs affecting the renin-angiotensin system &gt; 2.5.5.2 Angiotensin-II receptor antagonists</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/206641.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Losartan Potassium</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension &gt; 2.5.5 Drugs affecting the renin-angiotensin system &gt; 2.5.5.2 Angiotensin-II receptor antagonists &gt; LOSARTAN POTASSIUM</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22losartan+potassium%22%22losartan%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0961.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Losartan</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; L</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0011s0171.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Losartan Potassium</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; L</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/11145-s.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Losartan Potassium</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/05583.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Losartan</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; L &gt; LO</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E14E3E0R0D447.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Losartan</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; L</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c227.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Losartan potassium</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; L</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_27526">LOSARTAN POTASSIUM</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i108.htm" title="Go to appendix 1">Losartan</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">hypertension (including reduction of stroke risk in hypertension
with left ventricular hypertrophy); chronic heart failure when ACE
inhibitors are unsuitable or contra-indicated; diabetic nephropathy
in type 2 diabetes mellitus (see also notes above)</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">see <a title="target-block: A-II rec antag cautions" href="27513.htm#_27513.1">notes above</a>; severe heart failure</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">consider dose reduction in mild to moderate impairment;
manufacturer advises avoid in severe impairment—no information available</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">see <a title="BNF:target-block: Angiotensin II receptor antagonists in pregnancy" href="27513.htm#_204167">notes above</a></p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">see <a title="BNF:target-block: Angiotensin II receptor antagonists in breast-feeding" href="27513.htm#_204168">notes above</a></p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">see notes above; vertigo; <i>less commonly</i> gastro-intestinal disturbances, angina, palpitation, oedema, dyspnoea,
headache, sleep disorders, malaise, urticaria, pruritus, rash; <i>rarely</i> hepatitis, atrial fibrillation, cerebrovascular accident,
syncope, paraesthesia; also reported pancreatitis, anaphylaxis, cough,
depression, erectile dysfunction, anaemia, thrombocytopenia, hyponatraemia,
arthralgia, myalgia, renal impairment, rhabdomyolysis, tinnitus, photosensitivity,
and vasculitis (including Henoch-Schönlein purpura)</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">Hypertension, diabetic nephropathy in type 2 diabetes
mellitus, usually 50 mg once daily (intravascular volume depletion,
initially 25 mg once daily); if necessary increased after several
weeks to 100 mg once daily; <span class="cAK">elderly</span> over 75 years initially 25 mg daily</p><p class="cR">Chronic heart failure, initially 12.5 mg once daily, increased
at weekly intervals to max. 150 mg once daily if tolerated</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="208577.htm#_208577" title="Losartan Potassium">Losartan Potassium</a></li><li><a href="27527.htm#_27527" title="Cozaar®">Cozaar®</a></li><li><h1 class="title">With diuretic</h1><div class="cAR"><h3>Note</h3> <p class="cAX">For hypertension not adequately controlled
with losartan alone. For prescribing information on thiazides, see <a title="sub-section: Thiazides and related diuretics" href="2323.htm#_2323">section 2.2.1</a></p></div><ul><li><a href="215497.htm#_215497" title="Losartan potassium with hydrochlorothiazide">Losartan potassium with hydrochlorothiazide</a></li><li class="jN" id="_60326" style="margin: 0 0 0 20px;"><h1 class="title">Cozaar-Comp®<span> (<a href="appendix-112803-M.htm#m200">MSD</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Tablets 50/12.5</span>, yellow, f/c, <span>losartan potassium</span> 50 mg, <span>hydrochlorothiazide</span> 12.5 mg, net price 28-tab pack = £12.80</div><div class="cAY"><span class="cAB">Tablets 100/12.5</span>, white, f/c, <span>losartan potassium</span> 100 mg, <span>hydrochlorothiazide</span> 12.5 mg, net price 28-tab pack = £16.18</div><div class="cAY"><span class="cAB">Tablets 100/25</span>, yellow, f/c, <span>losartan potassium</span> 100 mg, <span>hydrochlorothiazide</span> 25 mg, net price 28-tab pack = £16.18</div></li></ul></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="64883.htm">Previous: IRBESARTAN</a> | <a class="top" href="60326.htm#">Top</a> | <a accesskey="]" href="127965.htm">Next: OLMESARTAN MEDOXOMIL</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>